Asset
Treprostinil
Liquidia Corporation Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07285655 | phase3 | recruiting | 2026-04-23 | 2029-07-01 | Liquidia Technologies, Inc. | A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD |
FDA applications (0)
This company has no applications containing this asset.